These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

657 related articles for article (PubMed ID: 32213338)

  • 21. International Validation of the EORTC QLQ-ANL27, a Field Study to Test the Anal Cancer-Specific Health-Related Quality-of-Life Questionnaire.
    Sodergren SC; Johnson CD; Gilbert A; Darlington AS; Cocks K; Guren MG; Rivin Del Campo E; Brannan C; Christensen P; Chu W; Chung H; Dennis K; Desideri I; Gilbert DC; Glynne-Jones R; Jefford M; Johansson M; Johnsson A; Juul T; Kardamakis D; Lai-Kwon J; McFarlane V; Miguel IMC; Nugent K; Peters F; Riechelmann RP; Turhal NS; Wong S; Vassiliou V;
    Int J Radiat Oncol Biol Phys; 2023 Apr; 115(5):1155-1164. PubMed ID: 36402360
    [TBL] [Abstract][Full Text] [Related]  

  • 22. International cross-cultural field validation of an European Organization for Research and Treatment of Cancer questionnaire module for patients with primary liver cancer, the European Organization for Research and Treatment of Cancer quality-of-life questionnaire HCC18.
    Chie WC; Blazeby JM; Hsiao CF; Chiu HC; Poon RT; Mikoshiba N; Al-Kadhimi G; Heaton N; Calara J; Collins P; Caddick K; Costantini A; Vilgrain V; Trinquart L; Chiang C;
    Hepatology; 2012 Apr; 55(4):1122-9. PubMed ID: 22105642
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Underlying dimensions of the EORTC QLQ-C30 in a Cuban population of patients with advanced non-small cell lung cancer.
    Viada C; Bouza C; Fors M; Frías A; Alvarez M; García L; Wilkinson B; Rodríguez C; Crombet T; Ballesteros J
    Qual Life Res; 2020 Dec; 29(12):3441-3448. PubMed ID: 33136243
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cultural adaptation and validation of the Korean version of the EORTC QLQ-CR29 in patients with colorectal cancer.
    Ihn MH; Lee SM; Son IT; Park JT; Oh HK; Kim DW; Kang SB
    Support Care Cancer; 2015 Dec; 23(12):3493-501. PubMed ID: 25824366
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Health-related quality-of-life results for pembrolizumab versus chemotherapy in advanced, PD-L1-positive NSCLC (KEYNOTE-024): a multicentre, international, randomised, open-label phase 3 trial.
    Brahmer JR; Rodríguez-Abreu D; Robinson AG; Hui R; Csőszi T; Fülöp A; Gottfried M; Peled N; Tafreshi A; Cuffe S; O'Brien M; Rao S; Hotta K; Zhang J; Lubiniecki GM; Deitz AC; Rangwala R; Reck M
    Lancet Oncol; 2017 Dec; 18(12):1600-1609. PubMed ID: 29129441
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Psychometric properties of the Arabic version of EORTC QLQ-C15-PAL among cancer patients in Jordan.
    Alawneh A; Yasin H; Khirfan G; Qayas BA; Ammar K; Rimawi D; Klepstad P
    Support Care Cancer; 2016 Jun; 24(6):2455-62. PubMed ID: 26660151
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Assessing the EORTC QLQ-BM22 Module Using Rasch Modeling and Confirmatory Factor Analysis across Countries: a Comprehensive Psychometric Evaluation in Patients with Bone Metastases.
    Lin CY; Pakpour AH
    Asian Pac J Cancer Prev; 2016; 17(3):1405-10. PubMed ID: 27039780
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Psychometric properties of the EORTC QLQ-C30 in Uganda.
    Naamala A; Eriksson LE; Orem J; Nalwadda GK; Kabir ZN; Wettergren L
    Health Qual Life Outcomes; 2021 Apr; 19(1):131. PubMed ID: 33892718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A large scale prospective clinical and psychometric validation of the EORTC colorectal (QLQ-CR29) module in Polish patients with colorectal cancer.
    Sanna B; Bereza K; Paradowska D; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Golec J; Bottomley A; Tomaszewski KA
    Eur J Cancer Care (Engl); 2017 Nov; 26(6):. PubMed ID: 28497549
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A prospective study to validate the Polish language version of the European Organisation for Research and Treatment of Cancer (EORTC) Colorectal Liver Metastases (QLQ-LMC21) module.
    Paradowska D; Bereza K; Sanna B; Kucharska E; Tomaszewska IM; Dudkiewicz Z; Skotnicki P; Bottomley A; Tomaszewski KA
    Eur J Oncol Nurs; 2017 Aug; 29():148-154. PubMed ID: 28578847
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Translation and validation of Sinhala version of modified EORTC QLQ-OH15 in oral cancer patients who receive radiotherapy with or without chemotherapy in Sri Lanka.
    Kosgallana S; Jayasekara P; Abeysinghe P; Hjermstad M; Lalloo R
    BMC Oral Health; 2022 Aug; 22(1):359. PubMed ID: 35986341
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer.
    Blazeby JM; Conroy T; Hammerlid E; Fayers P; Sezer O; Koller M; Arraras J; Bottomley A; Vickery CW; Etienne PL; Alderson D;
    Eur J Cancer; 2003 Jul; 39(10):1384-94. PubMed ID: 12826041
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Validation of the Japanese version of the EORTC hepatocellular carcinoma-specific quality of life questionnaire module (QLQ-HCC18).
    Mikoshiba N; Tateishi R; Tanaka M; Sakai T; Blazeby JM; Kokudo N; Koike K; Kazuma K
    Health Qual Life Outcomes; 2012 May; 10():58. PubMed ID: 22651810
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of the Danish version of the disease specific instrument EORTC QLQ-CR38 to assess health-related quality of life in patients with colorectal cancer.
    Thaysen HV; Jess P; Laurberg S; Groenvold M
    Health Qual Life Outcomes; 2012 Dec; 10():150. PubMed ID: 23241096
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Psychometric Validation of the Bahasa Malaysia Version of the EORTC QLQ-CR29.
    Magaji BA; Moy FM; Roslani AC; Law CW; Raduan F; Sagap I
    Asian Pac J Cancer Prev; 2015; 16(18):8101-5. PubMed ID: 26745045
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Translation and validation of EORTC QLQ-H&N 35 into Moroccan Arabic for ENT head and neck cancer patients in Morocco.
    Ouattassi N; Benmansour N; ElFakir S; Nejjari C; Alami MN
    Eur Arch Otorhinolaryngol; 2016 Sep; 273(9):2727-34. PubMed ID: 26506999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Translation and validation of the EORTC brain cancer module (EORTC QLQ-BN20) for use in Iran.
    Khoshnevisan A; Yekaninejad MS; Ardakani SK; Pakpour AH; Mardani A; Aaronson NK
    Health Qual Life Outcomes; 2012 May; 10():54. PubMed ID: 22607028
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancer.
    Whistance RN; Conroy T; Chie W; Costantini A; Sezer O; Koller M; Johnson CD; Pilkington SA; Arraras J; Ben-Josef E; Pullyblank AM; Fayers P; Blazeby JM;
    Eur J Cancer; 2009 Nov; 45(17):3017-26. PubMed ID: 19765978
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An international validation study of the EORTC brain cancer module (EORTC QLQ-BN20) for assessing health-related quality of life and symptoms in brain cancer patients.
    Taphoorn MJ; Claassens L; Aaronson NK; Coens C; Mauer M; Osoba D; Stupp R; Mirimanoff RO; van den Bent MJ; Bottomley A;
    Eur J Cancer; 2010 Apr; 46(6):1033-40. PubMed ID: 20181476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. International validation of the EORTC QLQ-PRT20 module for assessment of quality of life symptoms relating to radiation proctitis: a phase IV study.
    Halkett GKB; Wigley CA; Aoun SM; Portaluri M; Tramacere F; Livi L; Detti B; Arcangeli S; Lund JA; Kristensen A; McFadden N; Grun A; Bydder S; Sackerer I; Greimel E; Spry N;
    Radiat Oncol; 2018 Aug; 13(1):162. PubMed ID: 30157890
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 33.